MINI FUTURE SHORT - ROCHE GS Share Price

Certificat

DX3NB

NLBNPNL2NA43

Real-time Euronext Paris 11:18:41 14/05/2024 BST
5.25 EUR +11.23% Intraday chart for MINI FUTURE SHORT - ROCHE GS
Current month-13.39%
1 month-6.72%
Date Price Change
14/05/24 5.25 +11.23%
13/05/24 4.72 -5.79%
10/05/24 5.01 -6.00%
08/05/24 5.33 -0.93%
07/05/24 5.38 -4.61%

Real-time Euronext Paris

Last update May 14, 2024 at 11:18 am

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer BNP Paribas BNP Paribas
DX3NB
ISINNLBNPNL2NA43
Date issued 07/02/2024
Strike 273.8 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 6.08
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 6.53
Lowest since issue 4.04
Spread 0.02
Spread %0.38%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
227.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+22.65%
Consensus
  1. Stock Market
  2. Certificates
  3. DX3NB Certificat